Results 71 to 80 of about 21,376,824 (184)

Overview of P-glycoprotein inhibitors: a rational outlook

open access: yesBrazilian Journal of Pharmaceutical Sciences, 2012
P-glycoprotein (P-gp), a transmembrane permeability glycoprotein, is a member of ATP binding cassette (ABC) super family that functions specifically as a carrier mediated primary active efflux transporter. It is widely distributed throughout the body and
Kale Mohana Raghava Srivalli   +1 more
doaj   +1 more source

Inhibitory Effects of Salinispora-derived Metabolites Against Multidrug Resistance: An In-silico Study

open access: yesPharmaceutical and Biomedical Research, 2020
Background: Multi drug resistance (MDR) is known to defeat most chemotherapies as one of the main anticancer strategies. The role of overexpression or overactivation of ATP-binding cassette (ABC) transporters, especially P-glycoprotein (P-gp), in the ...
Morteza Ghandadi
doaj  

Marine Natural Products with P-Glycoprotein Inhibitor Properties

open access: yesMarine Drugs, 2014
P-glycoprotein (P-gp) is a protein belonging to the ATP-binding cassette (ABC) transporters superfamily that has clinical relevance due to its role in drug metabolism and multi-drug resistance (MDR) in several human pathogens and diseases.
Dioxelis Lopez, Sergio Martinez-Luis
doaj   +1 more source

P-glycoprotein [PDF]

open access: yesJournal of Biological Chemistry, 1995
Tip W. Loo, David M. Clarke
openaire   +1 more source

The translocation mechanism of P‐glycoprotein

open access: yesFEBS Letters, 2005
Multidrug transporters are involved in mediating the failure of chemotherapy in treating several serious diseases. The archetypal multidrug transporter P‐glycoprotein (P‐gp) confers resistance to a large number of chemically and functionally unrelated anti‐cancer drugs by mediating efflux from cancer cells.
Callaghan, Richard   +2 more
openaire   +2 more sources

Slipping past P glycoprotein [PDF]

open access: yesScience-Business eXchange, 2012
NIH researchers have shown that sphingosine 1-phosphate receptor agonists such as Novartis' Gilenya could transiently reduce P glycoprotein–mediated drug efflux and enhance drug delivery to the brain. The group is evaluating the approach for improving drug delivery to brain tumors.
openaire   +1 more source

P-glycoprotein and its role in drug-drug interactions

open access: yes, 2014
Efflux transporters such as P-glycoprotein play an important role in drug transport in many organs. In the gut, P-glycoprotein pumps drugs back into the lumen, decreasing their absorption. Drugs which induce P-glycoprotein, such as rifampicin, can reduce
A. Finch, P. Pillans
semanticscholar   +1 more source

The Sister of P-glycoprotein Represents the Canalicular Bile Salt Export Pump of Mammalian Liver*

open access: yesJournal of Biological Chemistry, 1998
Canalicular secretion of bile salts is a vital function of the vertebrate liver, yet the molecular identity of the involved ATP-dependent carrier protein has not been elucidated.
T. Gerloff   +7 more
semanticscholar   +1 more source

P-glycoprotein

open access: yes
Citation: 'P-glycoprotein' in the IUPAC Compendium of Chemical Terminology, 5th ed.; International Union of Pure and Applied Chemistry; 2025. Online version 5.0.0, 2025. 10.1351/goldbook.12704 • License: The IUPAC Gold Book is licensed under Creative Commons Attribution-ShareAlike CC BY-SA 4.0 International for individual terms.
openaire   +1 more source

Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo.

open access: yesProceedings of the National Academy of Sciences of the United States of America, 2000
Sven Hoffmeyer   +10 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy